[Asia Economy Reporter Han Seung-gon] Jeong Eun-kyung, head of the Central Disease Control Headquarters (CDCH), stated at the regular briefing on the 1st, "There are currently about 33 severe patients, and they will likely be the first candidates for administration," adding, "The decision to administer the drug is made by the attending physician."


The health authorities said that, so far, no serious side effects of Remdesivir have been reported, but a monitoring system has also been established to observe any adverse reactions following administration.





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing